LP533401 treatment alters vitamin K metabolism, bone Gla-OC/Glu-OC ratios, and improves mineral status of the skeleton in rats with chronic kidney disease.

Kopańko M, Sieklucka B, Pawlak D, Zabłudowska M, Sokołowska K, Łebkowska U, Pawlak K

Open source

DOI
10.3389/fphar.2026.1793663
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1793663,
  title = {LP533401 treatment alters vitamin K metabolism, bone Gla-OC/Glu-OC ratios, and improves mineral status of the skeleton in rats with chronic kidney disease.},
  author = {Kopańko M and Sieklucka B and Pawlak D and Zabłudowska M and Sokołowska K and Łebkowska U and Pawlak K},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1793663},
  url = {https://doi.org/10.3389/fphar.2026.1793663}
}

RIS

TY  - JOUR
TI  - LP533401 treatment alters vitamin K metabolism, bone Gla-OC/Glu-OC ratios, and improves mineral status of the skeleton in rats with chronic kidney disease.
AU  - Kopańko M
AU  - Sieklucka B
AU  - Pawlak D
AU  - Zabłudowska M
AU  - Sokołowska K
AU  - Łebkowska U
AU  - Pawlak K
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1793663
UR  - https://doi.org/10.3389/fphar.2026.1793663
ER  - 

APA

M, K., B, S., D, P., M, Z., K, S., U, Ł., & K, P. (2026). LP533401 treatment alters vitamin K metabolism, bone Gla-OC/Glu-OC ratios, and improves mineral status of the skeleton in rats with chronic kidney disease.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1793663

Source records